115 related articles for article (PubMed ID: 9865426)
21. Reliability of rectal epithelial kinetic patterns as an intermediate biomarker of colon cancer.
Anti M; Marra G; Percesepe A; Armelao F; Gasbarrini G
J Cell Biochem Suppl; 1994; 19():68-75. PubMed ID: 7823608
[TBL] [Abstract][Full Text] [Related]
22. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
23. Butyrate inhibits deoxycholate-induced increase in colonic mucosal DNA and protein synthesis in vivo.
Velázquez OC; Seto RW; Choi J; Zhou D; Breen F; Fisher JD; Rombeau JL
Dis Colon Rectum; 1997 Nov; 40(11):1368-75. PubMed ID: 9369115
[TBL] [Abstract][Full Text] [Related]
24. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
Raju J; Patlolla JM; Swamy MV; Rao CV
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
[TBL] [Abstract][Full Text] [Related]
25. Different effects of bile acids, ursodeoxycholic acid and deoxycholic acid, on cell growth and cell death in human colonic adenocarcinoma cells.
Shiraki K; Ito T; Sugimoto K; Fuke H; Inoue T; Miyashita K; Yamanaka T; Suzuki M; Nabeshima K; Nakano T; Takase K
Int J Mol Med; 2005 Oct; 16(4):729-33. PubMed ID: 16142412
[TBL] [Abstract][Full Text] [Related]
26. The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-kappaB activation in oesophageal cells, with a mechanism of action involving ROS.
Jenkins GJ; Cronin J; Alhamdani A; Rawat N; D'Souza F; Thomas T; Eltahir Z; Griffiths AP; Baxter JN
Mutagenesis; 2008 Sep; 23(5):399-405. PubMed ID: 18515815
[TBL] [Abstract][Full Text] [Related]
27. Colonic mucosal proliferation is related to serum deoxycholic acid levels.
Ochsenkühn T; Bayerdörffer E; Meining A; Schinkel M; Thiede C; Nüssler V; Sackmann M; Hatz R; Neubauer A; Paumgartner G
Cancer; 1999 Apr; 85(8):1664-9. PubMed ID: 10223558
[TBL] [Abstract][Full Text] [Related]
28. Chemopreventive effects of lupulone, a hop {beta}-acid, on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis.
Lamy V; Roussi S; Chaabi M; Gossé F; Schall N; Lobstein A; Raul F
Carcinogenesis; 2007 Jul; 28(7):1575-81. PubMed ID: 17434926
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of disodium ethylenediaminetetraacetate, theophylline, and deoxycholic acid on colonic ion transport and permeability.
Argenzio RA; Whipp SC
Am J Vet Res; 1983 Aug; 44(8):1480-7. PubMed ID: 6312851
[TBL] [Abstract][Full Text] [Related]
30. K-ras point mutation is associated with enhancement by deoxycholic acid of colon carcinogenesis induced by azoxymethane, but not with its attenuation by all-trans-retinoic acid.
Narahara H; Tatsuta M; Iishi H; Baba M; Uedo N; Sakai N; Yano H; Ishiguro S
Int J Cancer; 2000 Oct; 88(2):157-61. PubMed ID: 11004662
[TBL] [Abstract][Full Text] [Related]
31. Enantiomeric deoxycholic acid: total synthesis, characterization, and preliminary toxicity toward colon cancer cell lines.
Katona BW; Rath NP; Anant S; Stenson WF; Covey DF
J Org Chem; 2007 Nov; 72(24):9298-307. PubMed ID: 17958446
[TBL] [Abstract][Full Text] [Related]
32. Summary of recommendations for colonic biomarker studies of candidate chemopreventive compounds in phase II clinical trials.
Lipkin M
J Cell Biochem Suppl; 1994; 19():94-8. PubMed ID: 7823612
[TBL] [Abstract][Full Text] [Related]
33. In vivo crypt surface hyperproliferation is decreased by butyrate and increased by deoxycholate in normal rat colon: associated in vivo effects on c-Fos and c-Jun expression.
Velázquez OC; Zhou D; Seto RW; Jabbar A; Choi J; Lederer HM; Rombeau JL
JPEN J Parenter Enteral Nutr; 1996; 20(4):243-50. PubMed ID: 8865104
[TBL] [Abstract][Full Text] [Related]
34. Effect of ursodeoxycholic acid on azoxymethane-induced aberrant crypt foci formation in rat colon: in vitro potential role of intracellular Ca2+.
Momen MA; Monden Y; Houchi H; Umemoto A
J Med Invest; 2002 Feb; 49(1-2):67-73. PubMed ID: 11901763
[TBL] [Abstract][Full Text] [Related]
35. Lack of chemoprevention of dietary Agaricus blazei against rat colonic aberrant crypt foci.
Ziliotto L; Barbisan LF; Rodrigues MA
Hum Exp Toxicol; 2008 Jun; 27(6):505-11. PubMed ID: 18784204
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells.
Mühlbauer M; Allard B; Bosserhoff AK; Kiessling S; Herfarth H; Rogler G; Schölmerich J; Jobin C; Hellerbrand C
Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G1000-8. PubMed ID: 14726307
[TBL] [Abstract][Full Text] [Related]
37. Laxatives and intestinal epithelial cells: a morphological study of epithelial cell damage and proliferation.
Geboes K
Verh K Acad Geneeskd Belg; 1995; 57(1):51-74; discussion 74-7. PubMed ID: 7618371
[TBL] [Abstract][Full Text] [Related]
38. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
39. Bile acid-induced secretion in polarized monolayers of T84 colonic epithelial cells: Structure-activity relationships.
Keely SJ; Scharl MM; Bertelsen LS; Hagey LR; Barrett KE; Hofmann AF
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G290-7. PubMed ID: 16901996
[TBL] [Abstract][Full Text] [Related]
40. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.
Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T
Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
